查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1633752

美国透析中心市场：市场规模、份额、趋势分析（按方式、透析方法、设施和地区）、细分市场预测（2025-2030 年）

U.S. Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-center, In-home, SNF-based), By Dialysis (Hemodialysis, Peritoneal Dialysis, Dialysis Chains), By Facility, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

美国透析中心市场的成长与趋势：

根据Grand View Research的新报告，到2030年美国透析中心市场规模预计将达到403.9亿美元。

预计 2025 年至 2030 年期间市场复合年增长率为 5.4%。末期肾功能衰竭(ESRD) 的高盛行率和优惠的报销政策是预计推动成长的一些关键因素。由于ESRD盛行率不断上升，治疗费用也逐渐上升。

医疗保险可以报销肾衰竭治疗费用，增加了治疗的可近性。医疗保险和医疗补助服务中心宣布了一种新的末期肾病治疗选择模型，以维护和改善慢性肾臟病病患者的报销。这种新模式鼓励采用住院治疗。 2022 年 8 月，CMS 扩大了肾功能损害治疗的报销资格。扩建也包括某些资本资产，例如主要用于家庭治疗的设备。这增加了服务的可访问性。

由于患者每周大约有三天需要往返中心，因此距离患者居住近通常是选择中心的重要标准。因此，推出新工厂是领先公司增加市场占有率的关键策略倡议。例如，美国公司 RenalCare 于 2021 年 5 月开设了三家新工厂。这扩大了该公司在西南佛罗里达州的影响力。

新冠肺炎疫情导致末期肾病患者难以获得治疗，需要他们在一个月内接受多次治疗。根据美国国家肾臟基金会的数据，接受末期肾病治疗的患者中有 15.8% 感染了 COVID-19。联邦政府和服务提供者提倡住院治疗。 2021 年 6 月，九家领先的医疗保健组织发起了一项新的创新肾臟护理宣传活动，为患者提供在家接受治疗的选择。

美国透析中心市场：概述

  • 按服务划分，中心部门在 2024 年占据了最大的收入份额。这是因为透析中心需要更顺畅的透析协助和照护。此外，对血液透析机的高度偏好也推动了市场机会，因为血液透析机本质上需要去中心并得到帮助。
  • 根据透析方法的类型，血液透析机在 2024 年占据市场主导地位。这是由于医疗专业人员对血液透析机的偏好以及患者预期寿命的增加。然而，由于腹膜透析能有效清除毒性物质，且患者可在家中独立接受治疗，因此预计预测期内将以最快的速度成长。
  • 根据设施类型，透析连锁店在 2024 年占据了市场主导地位。这是因为美国各地都有这样的透析连锁店。与医院设施相比，以较低的成本提供高品质的设备和治疗是推动这一领域成长的原因。此外，主要企业正在收购独立设施，导致大多数独立设施由连锁店经营。
  • 自 COVID-19 疫情爆发以来，服务提供者和患者一直面临挑战，其中一些挑战与其他医疗机构和治疗团体相比是独一无二的。例如，血液透析机(HD) 患者每週至少访问中心三次，并且在每次治疗期间，他们会接触到在特定治疗期间同时接受治疗的所有患者，并且还会接触到在往返中心的途中额外接触的医护人员。
  • 併购与合作受到大型公司的青睐，因为它们可以透过增加服务价值来获得竞争优势。例如，2022年3月，费森尤斯医疗宣布与Interwell Health和Cricket Health合併，以推进更好的肾臟疾病解决方案。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章美国透析中心市场：驱动因素、趋势与范围

  • 市场联动展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章美国透析中心市场：按模式进行的业务分析

  • 按模式分類的市场占有率（2024 年和 2030 年）
  • 特定于模式的仪表板
  • 按模式分類的市场规模预测和趋势分析（2018-2030 年）
  • 中心内部
  • 在家里
  • 基于SNF

第 5 章美国透析中心市场：按透析方法进行的业务分析

  • 按透析方法分類的市场占有率（2024 年和 2030 年）
  • 按透析方法分類的仪表板
  • 透析法市场规模预测及趋势分析（2018-2030年）
  • 血液透析机
  • 腹膜透析

第六章美国透析中心市场：按设施分類的业务分析

  • 各设施市场占有率（2024 年及 2030 年）
  • 设施仪表板
  • 按设施分類的市场规模预测和趋势分析（2018 至 2030 年）
  • 透析链
  • 独立设施
  • 医院为基础

第 7 章：美国透析中心市场：按地区分類的估计和趋势分析

  • 各地区市场占有率（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 各地区市场规模预测及趋势分析（2018-2030年）
  • 西方
  • 中西部
  • 东北
  • 东南
  • 西南

第八章 竞争格局

  • 参与企业概况
  • 公司市场地位分析
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Fresenius Medical Care AG
    • US Renal Care, Inc.
    • DaVita Inc.
    • Innovative Renal Care
    • DCI
    • SATELLITE HEALTHCARE
    • Northwest Kidney Centers
    • Centers for Dialysis Care
    • Rogosin Institute
    • Dialysis Care Center
    • USCF Health（The Regents of The University of California）
    • Rhode Island Hospital, Department of Health Rhode Island
    • University of Iowa Hospital &Clinics
    • Saint Anthony Hospital
    • Rush University Children's Hospital
Product Code: GVR-4-68039-990-8

U.S. Dialysis Centers Market Growth & Trends:

The U.S. dialysis centers market size is expected to reach USD 40.39 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.4% from 2025 to 2030. The high prevalence of End-Stage Renal Disease (ESRD) and favorable reimbursement are some of the key factors expected to boost growth. The expenditure on treatment is gradually rising due to the increasing prevalence of ESRD.

The availability of Medicare reimbursement for kidney disorder treatment is increasing the accessibility to the treatment. The Center for Medicare & Medicaid Services announced a new end-stage renal diseases treatment choice model for the maintenance & improvement in the reimbursement for chronic kidney disorder patients. The new model is encouraging the use of home-based treatment. In August 2022, the CMS expanded the eligibility for reimbursement for kidney disorder treatment. The expansion includes certain capital assets, mainly equipment used at home for treatment. This is increasing the accessibility to the services.

The patients need to travel to and fro the center for around 3 days per week, the proximity from the patient's residence is generally an important criterion for the center of choice. Hence the launch of new facilities is a key strategic initiative undertaken by major players to increase their market share. For instance, in May 2021, U.S. Renal Care, Inc. inaugurated three new facilities, one in-center facility and two focusing on home therapies. This expanded the company's presence in the Southwest Florida region.

The COVID-19 pandemic resulted in patients facing difficulty in having an access to treatment for end-stage renal disorder, requiring multiple sessions within a month. According to the national kidney foundation, 15.8% of the patients undergoing treatment for end-stage renal disease had COVID-19 infection. The federal government & service providers promoted home treatment. In June 2021, a new campaign innovative kidney care was launched by nine leading healthcare organizations for patient options for receiving home treatment.

U.S. Dialysis Centers Market Report Highlights:

  • Based on service, the in-center segment held the largest revenue share in 2024. This can be attributed to the need for assistance & care for the procedure, which can be facilitated better at the centers. The high preference for hemodialysis is also driving the market opportunity as it essentially requires center visits & assistance.
  • Based on dialysis type, hemodialysis dominated the market in 2024. This can be attributed to the preference for the segment by healthcare professionals & longer life expectancy for patients. However peritoneal dialysis is expected to have the fastest growth during the forecast period owing to the effective removal of toxic substances & high convenience of peritoneal dialysis enabling patients to independently have treatment at home.
  • Based on facility type, dialysis chains dominated the market in 2024. This can be attributed to the presence of such chains throughout the U.S. The availability of top-quality equipment and treatment at a lower cost compared to hospital-based facilities is driving the segment's growth. In addition, the key players are acquiring independent facilities, resulting in most of the independent facilities being managed by chains.
  • The service providers and patients faced challenges since the onset of the COVID-19 pandemic, some of which are unique as compared to other health facilities and treatment groups. For instance, hemodialysis (HD) patients visit centers at least three times a week and during each session, the patients are exposed to all the patients concurrently receiving treatment in a particular session, and to healthcare personnel along with any additional exposure during their travel to and from the center.
  • Mergers & acquisitions and collaborations are being preferred by the key players, enabling them to have a competitive edge by adding value to their services. For Instance, in March 2022, Fresenius Medical Care announced a merger with InterWell Health and Cricket Health for facilitating better kidney disorder solutions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Dialysis
    • 1.2.3. Facility
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Dialysis Centers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Dialysis Centers Market: Modality Business Analysis

  • 4.1. Modality Market Share, 2024 & 2030
  • 4.2. Modality Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. In-center
    • 4.4.1. In-center Market, 2018 - 2030 (USD Million)
  • 4.5. In-home
    • 4.5.1. In-home Market, 2018 - 2030 (USD Million)
  • 4.6. SNF-based
    • 4.6.1. SNF-based Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Dialysis Centers Market: Dialysis Business Analysis

  • 5.1. Dialysis Market Share, 2024 & 2030
  • 5.2. Dialysis Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Dialysis, 2018 to 2030 (USD Million)
  • 5.4. Hemodialysis
    • 5.4.1. Hemodialysis Market, 2018 - 2030 (USD Million)
  • 5.5. Peritoneal Dialysis
    • 5.5.1. Peritoneal Dialysis Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Dialysis Centers Market: Facility Business Analysis

  • 6.1. Facility Market Share, 2024 & 2030
  • 6.2. Facility Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Facility, 2018 to 2030 (USD Million)
  • 6.4. Dialysis Chains
    • 6.4.1. Dialysis Chains Market, 2018 - 2030 (USD Million)
  • 6.5. Independent Facilities
    • 6.5.1. Independent Facilities Market, 2018 - 2030 (USD Million)
  • 6.6. Hospital-based
    • 6.6.1. Hospital-based Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Dialysis Centers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. West
    • 7.4.1. West U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Midwest
    • 7.5.1. Midwest U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Northeast
    • 7.6.1. Northeast U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Southeast
    • 7.7.1. Southeast U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Southwest
    • 7.8.1. Southwest U.S. Dialysis Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Fresenius Medical Care AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. U.S. Renal Care, Inc.
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. DaVita Inc.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Innovative Renal Care
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. DCI
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. SATELLITE HEALTHCARE
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Northwest Kidney Centers
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Centers for Dialysis Care
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Rogosin Institute
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Dialysis Care Center
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. USCF Health (The Regents of The University of California)
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Rhode Island Hospital, Department of Health Rhode Island
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. University of Iowa Hospital & Clinics
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Saint Anthony Hospital
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives
    • 8.5.15. Rush University Children's Hospital
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial Performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. dialysis centers market, by modality, 2018 - 2030 (USD Million)
  • Table 4 U.S. dialysis centers market, by dialysis, 2018 - 2030 (USD Million)
  • Table 5 U.S. dialysis centers market, by facility, 2018 - 2030 (USD Million)
  • Table 6 U.S. dialysis centers market, by region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. dialysis centers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Modality and dialysis outlook (USD Million)
  • Fig. 10 Facility outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 U.S. dialysis centers market dynamics
  • Fig. 13 U.S. dialysis centers market: Porter's five forces analysis
  • Fig. 14 U.S. dialysis centers market: PESTLE analysis
  • Fig. 15 U.S. dialysis centers market: Modality segment dashboard
  • Fig. 16 U.S. dialysis centers market: Modality market share analysis, 2024 & 2030
  • Fig. 17 In-center market, 2018 - 2030 (USD Million)
  • Fig. 18 In-home market, 2018 - 2030 (USD Million)
  • Fig. 19 SNF-based market, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. dialysis centers market: Dialysis segment dashboard
  • Fig. 21 U.S. dialysis centers market: Dialysis market share analysis, 2024 & 2030
  • Fig. 22 Hemodialysis market, 2018 - 2030 (USD Million)
  • Fig. 23 Peritoneal dialysis market, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. dialysis centers market: Facility segment dashboard
  • Fig. 25 U.S. dialysis centers market: Facility market share analysis, 2024 & 2030
  • Fig. 26 Dialysis chains market, 2018 - 2030 (USD Million)
  • Fig. 27 Independent facilities market, 2018 - 2030 (USD Million)
  • Fig. 28 Hospital-based market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. dialysis centers market revenue, by region
  • Fig. 30 Regional marketplace: Key takeaways
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 West U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 33 Midwest U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 34 Northeast U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 35 Southeast U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 36 Southwest U.S. dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 37 Company categorization
  • Fig. 38 Company market position analysis
  • Fig. 39 Strategic framework